Literature DB >> 11512487

Multidisciplinary teaming to promote effective management of type 1 diabetes for adolescents.

M T Strawhacker1.   

Abstract

Intensive diabetes therapy can reduce the long-term microvascular complications of Type 1 diabetes and improve glucose control. Managing the demands of intensive therapy however, often poses a burden on adolescents and their families. Through multidisciplinary teaming, the school health office can facilitate active participation in treatment, coordinate services, and maximize use of community resources. This paper presents a general overview of intensive diabetes therapy, psychosocial implications of chronic illness in adolescence, effects of chronic illness on the family, and behavior change strategies to improve adherence with disease management guidelines.

Entities:  

Mesh:

Year:  2001        PMID: 11512487     DOI: 10.1111/j.1746-1561.2001.tb01318.x

Source DB:  PubMed          Journal:  J Sch Health        ISSN: 0022-4391            Impact factor:   2.118


  4 in total

1.  Evaluation of the JuniorSTAR® Half-unit Insulin Pen in Young People with Type 1 Diabetes - User Perspectives.

Authors:  David Klonoff; Irina Nayberg; Ivana Rabbone; Wolfgang Landgraf; Catherine Domenger; Thomas Danne
Journal:  Eur Endocrinol       Date:  2013-08-23

Review 2.  New insights into managing the risk of hypoglycaemia associated with intermittent high-intensity exercise in individuals with type 1 diabetes mellitus: implications for existing guidelines.

Authors:  Kym J Guelfi; Timothy W Jones; Paul A Fournier
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 3.  Autonomy and insulin in adolescents with type 1 diabetes.

Authors:  Sarah J Comeaux; Sarah S Jaser
Journal:  Pediatr Diabetes       Date:  2010-11       Impact factor: 4.866

4.  Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis.

Authors:  Jeniece Trast Ilkowitz; Steven Choi; Michael L Rinke; Kathy Vandervoot; Rubina A Heptulla
Journal:  Qual Manag Health Care       Date:  2016 Oct/Dec       Impact factor: 0.926

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.